Literature DB >> 9147412

Modifications of neuronal phosphorylated tau immunoreactivity induced by NMDA toxicity.

P Couratier1, M Lesort, P Sindou, F Esclaire, C Yardin, J Hugon.   

Abstract

Glutamate toxicity has been involved in the pathophysiology of a large variety of neurodegenerative disorders. Tau Protein is a micro-tubule-associated protein that promotes microtubule polymerization and stabilization. Phosphorylated tau protein accumulates in paired helical neurofilaments, the major constituent of neurofibrillary tangles observed in the brain of patients suffering from Alzheimer disease (AD). In this study, using confocal laser microscopy and immunoblot analysis, we report that acute (500 mu M for 15 min) or chronic (20 mu M for 16 h) N-methyl-D-aspartate (NMDA) neuronal toxicities modify the immunoreactivity of phosphorylated tau. Neuronal degeneration produced by N-methyl-D-aspartate is associated with an augmented immunolabeling of phosphorylated tau proteins at serine 202 (AT8 antibody) as observed in paired helical neurofilaments. This finding could help to determine the cellular mechanisms at the origin of neuronal degeneration associated with modifications of phosphorylated tau immunoreactivity produced by receptor-mediated extracellular signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9147412     DOI: 10.1007/bf02815108

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  9 in total

1.  Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.

Authors:  W Danysz; C G Parsons; H J Mobius; A Stoffler; G Quack
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Neuronal expression of splice variants of "glial" glutamate transporters in brains afflicted by Alzheimer's disease: unmasking an intrinsic neuronal property.

Authors:  David V Pow; David G Cook
Journal:  Neurochem Res       Date:  2009-03-25       Impact factor: 3.996

Review 3.  In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease.

Authors:  Nadia Canu; Pietro Calissano
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

4.  Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.

Authors:  Hilda Martinez-Coria; Kim N Green; Lauren M Billings; Masashi Kitazawa; Miriam Albrecht; Gerhard Rammes; Chris G Parsons; Sandeep Gupta; Pradeep Banerjee; Frank M LaFerla
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

Review 5.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

6.  Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress.

Authors:  Said AbdAlla; Ahmed El Hakim; Ahmed Abdelbaset; Yasser Elfaramawy; Ursula Quitterer
Journal:  Biomed Res Int       Date:  2015-11-30       Impact factor: 3.411

7.  From single target to multitarget/network therapeutics in Alzheimer's therapy.

Authors:  Hailin Zheng; Mati Fridkin; Moussa Youdim
Journal:  Pharmaceuticals (Basel)       Date:  2014-01-23

Review 8.  One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug.

Authors:  Rebecca E Hughes; Katarina Nikolic; Rona R Ramsay
Journal:  Front Neurosci       Date:  2016-04-25       Impact factor: 4.677

Review 9.  Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles.

Authors:  Ha Thi Thu Do; Jungsook Cho
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.